TY  - JOUR
AU  - Rodríguez-Macías, Gabriela
AU  - Briz, Oscar
AU  - Cives-Losada, Candela
AU  - Chillón, María
AU  - Martínez-Laperche, Carolina
AU  - Martínez-Arranz, Ibon
AU  - González-Díaz, Marcos
AU  - Marin, Jose
AU  - Macias, Rocio
AU  - Buño Borde, Ismael
AU  - Díez Martín, José Luis
PY  - 2023
DO  - 10.3390/cancers15123145
UR  - https://hdl.handle.net/20.500.14352/103517
T2  - Cancers
AB  - Despite its often low efficacy and high toxicity, the standard treatment for acute myeloid leukemia (AML) is induction chemotherapy with cytarabine and idarubicin. Here, we have investigated the role of transporters and drug-metabolizing enzymes in...
LA  - eng
M2  - 3145
PB  - MPDI
KW  - AML
KW  - Blood cancer;
KW  - Chemotherapy
KW  - Chemoresistance
KW  - Prognosis
TI  - Role of Intracellular Drug Disposition in the Response of Acute Myeloid Leukemia to Cytarabine and Idarubicin Induction Chemotherapy
TY  - journal article
VL  - 15
ER  -